Publications by authors named "Claus Garbe"

100Publications

Epidemiology of Skin Cancer: Update 2019.

Adv Exp Med Biol 2020 ;1268:123-139

Division of Dermatooncology, Department of Dermatology, University Medical Center, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-030-46227-7_6DOI Listing
September 2020

Toxic epidermal necrolysis in a melanoma patient under targeted therapy with encorafenib and binimetinib.

J Dtsch Dermatol Ges 2020 Aug 9. Epub 2020 Aug 9.

Center for Dermatooncology, Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.14181DOI Listing
August 2020

Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition.

Cell Death Dis 2020 Jul 2;11(7):581. Epub 2020 Jul 2.

Division of Dermatooncology, Department of Dermatology, University of Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41419-020-2702-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385107PMC
July 2020

A Systematic Review and Meta-Analysis of Interventions for Actinic Keratosis from Post-Marketing Surveillance Trials.

J Clin Med 2020 Jul 15;9(7). Epub 2020 Jul 15.

Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm9072253DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408895PMC
July 2020

Dermatofluoroscopy diagnostics in different pigmented skin lesions: Strengths and weaknesses.

J Dtsch Dermatol Ges 2020 07 12;18(7):682-690. Epub 2020 Jul 12.

Center of Dermatooncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.14163DOI Listing
July 2020

Indirect Comparison of Combined BRAF and MEK Inhibition in Melanoma Patients with Elevated Baseline Lactate Dehydrogenase.

Acta Derm Venereol 2020 Jun 11;100(13):adv00174. Epub 2020 Jun 11.

Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Josef-Schneider-Str. 2, DE-97080 Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2340/00015555-3526DOI Listing
June 2020

Are Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy?

Cancers (Basel) 2020 Apr 28;12(5). Epub 2020 Apr 28.

Center for Dermatooncology, Department of Dermatology, University Hospital Tuebingen, Eberhard Karls University, 72076 Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12051101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281129PMC
April 2020

Primary Resistance to PD-1-Based Immunotherapy-A Study in 319 Patients with Stage IV Melanoma.

Cancers (Basel) 2020 Apr 22;12(4). Epub 2020 Apr 22.

Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tuebingen, 72076 Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12041027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226601PMC
April 2020

Updates and new perspectives in nonmelanoma skin cancer therapy: highlights from 'Immunotherapy Bridge'.

Immunotherapy 2020 02 24;12(3):167-174. Epub 2020 Mar 24.

Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2020-0042DOI Listing
February 2020

Influence of F-FDG PET/CT on clinical management and outcome in patients with advanced melanoma not primarily selected for surgery based on a linked evidence approach.

Eur J Nucl Med Mol Imaging 2020 Sep 2;47(10):2313-2321. Epub 2020 Mar 2.

Department of Diagnostic and Interventional Radiology, University Hospital of Tuebingen, Hoppe-Seyler-Straβe 3, 72076, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-020-04733-xDOI Listing
September 2020

Absolute and relative differential blood count predicts survival of AJCC stage I-II melanoma patients scheduled for sentinel lymph node biopsy.

Australas J Dermatol 2020 Aug 12;61(3):e310-e318. Epub 2020 Feb 12.

Department of Dermatology and Venereology, University Medical Center Tubingen, University Tubingen, Tubingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajd.13248DOI Listing
August 2020

Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma.

Eur J Cancer 2020 01 12;125:38-45. Epub 2019 Dec 12.

Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tuebingen, Tuebingen, Germany; Central Malignant Melanoma Registry (CMMR) of Germany, Tuebingen, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.10.027DOI Listing
January 2020

Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy.

J Dtsch Dermatol Ges 2020 Feb 9;18(2):136-139. Epub 2019 Dec 9.

Center for Dermato-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13991DOI Listing
February 2020

Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden.

Eur J Cancer 2019 12 31;123:83-91. Epub 2019 Oct 31.

Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Carl Neuberg Strasse 1, D-30625 Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.07.004DOI Listing
December 2019

Harmonisation of Outcome Parameters and Evaluation (HOPE) for actinic keratosis: protocol for the development of a core outcome set.

Trials 2019 Oct 11;20(1):589. Epub 2019 Oct 11.

Department of Dermatology and Allergy, University Hospital, LMU Munich, Frauenlobstr. 9-11, 80337, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13063-019-3696-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787971PMC
October 2019

S1-Leitlinie Dermatofibrosarcoma protuberans (DFSP) - Update 2018.

J Dtsch Dermatol Ges 2019 Jun;17(6):663-668

Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Mainz.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13849_gDOI Listing
June 2019

Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma.

Eur J Cancer 2019 07 15;116:207-215. Epub 2019 Jun 15.

Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.05.015DOI Listing
July 2019

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.

N Engl J Med 2019 08 4;381(7):626-636. Epub 2019 Jun 4.

From Institut Gustave Roussy and Paris-Sud-Paris-Saclay University, Villejuif (C.R.), Aix-Marseille University, Marseille (J.J.G.), and Assistance Publique-Hôpitaux de Paris Dermatology and Clinical Investigation Center, Unité 976, Université de Paris, Hôpital Saint-Louis, Paris (C.L.) - all in France; Moscow City Oncology Hospital, Moscow (D. Stroyakovskiy), and the Petrov Research Institute of Oncology, St. Petersburg (E.L.) - both in Russia; Przychodnia Lekarska Komed, Konin (B.K.), the University of Medical Sciences, Poznań (A.M.), and the Maria Skłodowska-Curie Institute-Oncology Center, Warsaw (P.R.) - all in Poland; the University Hospital Schleswig-Holstein, Kiel (A.H.), the Department of Dermatology, University of Tübingen, Tübingen (C.G.), University Hospital Essen, Essen (D. Schadendorf), and the German Cancer Consortium, Heidelberg (D. Schadendorf) - all in Germany; the Veneto Institute of Oncology, Padua (V.C.S.), and Papa Giovanni XXIII Hospital, Bergamo (M.M.) - both in Italy; the Ella Lemelbaum Institute for Immuno-Oncology and Melanoma, Sheba Medical Center, Tel Hashomer (J.S.), and Sackler Medical School, Tel Aviv University, Tel Aviv (J.S.) - both in Israel; Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine (I.B.); Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens (H.G.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); Mount Vernon Cancer Centre, Northwood, United Kingdom (P.D.N.); the University of California, Los Angeles, Los Angeles (A.R.); the University of Texas M.D. Anderson Cancer Center, Houston (M.A.D.); Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (K.T.F.); Novartis Pharma, Basel, Switzerland (P.B.); Novartis Pharmaceuticals, East Hanover, NJ (M.T., E.G., M.V.); and the Melanoma Institute Australia, the University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1904059DOI Listing
August 2019

S1 guidelines for dermatofibrosarcoma protuberans (DFSP) - update 2018.

J Dtsch Dermatol Ges 2019 Jun 22;17(6):663-668. Epub 2019 May 22.

Department of Dermatology, Venereology and Allergology, University Medical Center, Mainz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13849DOI Listing
June 2019

Meningeal enhancement depicted by magnetic resonance imaging in tumor patients: neoplastic meningitis or therapy-related enhancement?

Neuroradiology 2019 Jul 18;61(7):775-782. Epub 2019 Apr 18.

Diagnostic and Interventional Neuroradiology, Eberhard Karls University Tuebingen, Hoppe-Seyler-Str. 3, 72076, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00234-019-02215-y
Publisher Site
http://dx.doi.org/10.1007/s00234-019-02215-yDOI Listing
July 2019

Age as key factor for pattern, timing, and extent of distant metastasis in patients with cutaneous melanoma: A study of the German Central Malignant Melanoma Registry.

J Am Acad Dermatol 2019 May 29;80(5):1299-1307.e7. Epub 2019 Jan 29.

Center for Dermatooncology, Department of Dermatology, Eberhard-Karls-University of Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2019.01.044DOI Listing
May 2019

Kein Überlebensvorteil beim Sentinel-Lymphknoten-positiven Melanom mit sofortiger kompletter Lymphadenektomie - eine Übersicht.

J Dtsch Dermatol Ges 2019 Jan;17(1):7-14

Zentrum für Dermatoonkologie, Universitäts-Hautklinik, Eberhard Karls Universität, Tübingen.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13707_gDOI Listing
January 2019

Modifiable Risk-factors for Keratinocyte Cancers in Australia: A Case-control Study.

Acta Derm Venereol 2019 Apr;99(4):404-411

Department of Clinical Epidemiology and Applied Biostatistics, University Hospital Tübingen, DE-72076 Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2340/00015555-3107DOI Listing
April 2019

Lack of survival benefit in sentinel lymph node-positive melanoma with immediate complete lymphadenectomy - a review.

J Dtsch Dermatol Ges 2019 Jan 3;17(1):7-13. Epub 2018 Dec 3.

Centre for Dermato-oncology, University Department of Dermatology, Eberhard Karls University, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13707DOI Listing
January 2019

BRAF mutation testing in melanoma: results from a German observational multicenter study.

Virchows Arch 2019 Jan 7;474(1):71-78. Epub 2018 Nov 7.

Division of Dermato-Oncology, University-Department of Dermatology, Liebermeisterstr. 25, 72076, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00428-018-2480-4
Publisher Site
http://dx.doi.org/10.1007/s00428-018-2480-4DOI Listing
January 2019

Accurate quantification of T-cells expressing PD-1 in patients on anti-PD-1 immunotherapy.

Cancer Immunol Immunother 2018 Dec 14;67(12):1845-1851. Epub 2018 Sep 14.

Department of Dermatology, University Medical Center Tübingen, Liebermeisterstraße 25, 72076, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-018-2244-7
Publisher Site
http://dx.doi.org/10.1007/s00262-018-2244-7DOI Listing
December 2018

Vemurafenib.

Recent Results Cancer Res 2018;211:77-89

Division of Dermatooncology, Department of Dermatology, University Medical Centre, Liebermeisterstr. 25, 72074, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-91442-8_6DOI Listing
November 2018

Patientenakzeptanz und -vertrauen in die automatisierte, computergestützte Diagnostik des Melanoms mithilfe der Dermatofluoroskopie.

J Dtsch Dermatol Ges 2018 Jul;16(7):854-860

Department of Dermatology, University Medical Center, Ruprecht Karls University Heidelberg, Germany (Hautklinik, Universitätsklinikum Heidelberg, Ruprecht-Karls-Universität Heidelberg, Deutschland).

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ddg.13562_g
Publisher Site
http://dx.doi.org/10.1111/ddg.13562_gDOI Listing
July 2018

S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies.

Br J Cancer 2018 08 28;119(3):339-346. Epub 2018 Jun 28.

Department of Dermatology, University Hospital Tuebingen, Liebermeisterstrasse 25, 72076, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0167-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070917PMC
August 2018

Patient acceptance and trust in automated computer-assisted diagnosis of melanoma with dermatofluoroscopy.

J Dtsch Dermatol Ges 2018 Jul 21;16(7):854-859. Epub 2018 Jun 21.

Department of Dermatology, University Medical Center, Ruprecht Karl University, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ddg.13562
Publisher Site
http://dx.doi.org/10.1111/ddg.13562DOI Listing
July 2018

Embryonic bone morphogenetic protein and nodal induce invasion in melanocytes and melanoma cells.

Biol Open 2018 Jun 7;7(6). Epub 2018 Jun 7.

Section of Dermato-Oncology, Department of Dermatology, Tuebingen University Hospital, Liebermeisterstrasse 25, 72076 Tuebingen, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1242/bio.032656DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031345PMC
June 2018

Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.

Mol Cancer 2018 02 17;17(1):59. Epub 2018 Feb 17.

Center for Dermatooncology, Department of Dermatology, University Hospital Tübingen, University of Tübingen, Liebermeisterstr.25, 72076, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12943-018-0773-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816360PMC
February 2018

The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival.

Eur J Cancer 2018 03 6;91:1-10. Epub 2018 Jan 6.

Experimental Medicine and Therapy Research, University of Regensburg, Franz-Josef Strauß Allee 11, 93053 Regensburg, Germany; Fraunhofer Institute of Toxicology and Experimental Medicine Regensburg ITEM-R, Division Personalized Tumour Therapy, Am Biopark 9, Regensburg, 93053, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.12.002DOI Listing
March 2018

How to use neoadjuvant medical treatment to maximize surgery in melanoma.

Expert Rev Anticancer Ther 2018 02 3;18(2):121-130. Epub 2018 Jan 3.

a Center for Dermatooncology, Department of Dermatology , University Hospital Tübingen , Tübingen , Germany.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14737140.2018.1
Publisher Site
http://dx.doi.org/10.1080/14737140.2018.1421460DOI Listing
February 2018